Cencora, Inc. $COR Shares Sold by American Century Companies Inc.

American Century Companies Inc. lowered its position in Cencora, Inc. (NYSE:COR) by 6.3% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 962,413 shares of the company’s stock after selling 64,790 shares during the quarter. American Century Companies Inc. owned 0.50% of Cencora worth $300,784,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors also recently modified their holdings of the company. IAG Wealth Partners LLC bought a new position in Cencora during the 3rd quarter valued at $30,000. Vermillion & White Wealth Management Group LLC grew its stake in Cencora by 69.4% during the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 105 shares of the company’s stock worth $31,000 after buying an additional 43 shares during the last quarter. Cloud Capital Management LLC bought a new stake in Cencora in the 3rd quarter valued at about $31,000. Caitlin John LLC acquired a new position in shares of Cencora during the third quarter worth approximately $31,000. Finally, Westside Investment Management Inc. increased its stake in Cencora by 200.0% during the 3rd quarter. Westside Investment Management Inc. now owns 105 shares of the company’s stock valued at $33,000 after buying an additional 70 shares during the period. Institutional investors and hedge funds own 97.52% of the company’s stock.

Cencora Trading Up 1.4%

Shares of NYSE COR opened at $371.86 on Friday. The stock has a market cap of $72.34 billion, a price-to-earnings ratio of 44.69, a P/E/G ratio of 1.71 and a beta of 0.68. Cencora, Inc. has a twelve month low of $248.59 and a twelve month high of $377.54. The company has a quick ratio of 0.51, a current ratio of 0.92 and a debt-to-equity ratio of 3.62. The company’s fifty day moving average is $351.72 and its 200-day moving average is $333.58.

Cencora (NYSE:COR) last posted its earnings results on Wednesday, February 4th. The company reported $4.08 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.04 by $0.04. Cencora had a return on equity of 176.54% and a net margin of 0.50%.The firm had revenue of $85.93 billion during the quarter, compared to analysts’ expectations of $86.12 billion. During the same period in the previous year, the firm earned $3.73 earnings per share. The company’s revenue was up 5.5% on a year-over-year basis. Equities research analysts predict that Cencora, Inc. will post 15.37 EPS for the current year.

Cencora Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 2nd. Stockholders of record on Friday, February 13th will be given a $0.60 dividend. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date of this dividend is Friday, February 13th. Cencora’s payout ratio is currently 28.85%.

Analyst Ratings Changes

A number of research firms recently commented on COR. Evercore dropped their target price on shares of Cencora from $440.00 to $420.00 and set an “outperform” rating on the stock in a report on Thursday, February 5th. TD Cowen boosted their price target on shares of Cencora from $350.00 to $400.00 and gave the company a “buy” rating in a report on Monday, November 10th. Robert W. Baird set a $415.00 price target on shares of Cencora in a report on Tuesday, January 13th. UBS Group raised their target price on Cencora from $380.00 to $415.00 and gave the company a “buy” rating in a report on Friday, November 7th. Finally, Bank of America dropped their price objective on shares of Cencora from $380.00 to $360.00 and set a “neutral” rating on the stock in a report on Monday, January 5th. Eleven equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Cencora has an average rating of “Moderate Buy” and an average target price of $399.00.

Insider Activity

In related news, EVP Silvana Battaglia sold 1,677 shares of Cencora stock in a transaction dated Friday, December 19th. The stock was sold at an average price of $345.00, for a total value of $578,565.00. Following the sale, the executive vice president owned 18,796 shares of the company’s stock, valued at approximately $6,484,620. The trade was a 8.19% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Elizabeth S. Campbell sold 3,351 shares of Cencora stock in a transaction dated Friday, December 19th. The shares were sold at an average price of $342.10, for a total transaction of $1,146,377.10. Following the completion of the transaction, the executive vice president directly owned 23,891 shares of the company’s stock, valued at approximately $8,173,111.10. This trade represents a 12.30% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 15,220 shares of company stock worth $5,282,867 in the last quarter. Corporate insiders own 0.38% of the company’s stock.

Cencora Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.